Tuesday’s Midday Stock Update: Inovio Pharmaceuticals (INO), Kandi Technologies (KNDI), Novavax (NVAX), Zogenix (ZGNX), Walgreens Boots Alliance (WBA)

So far Tuesday, November 10, NASDAQ is down -3.14% and the S&P is up 0.18%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Inovio Pharmaceuticals (INOResearch Report), Kandi Technologies (KNDIResearch Report), Novavax (NVAXResearch Report), Zogenix (ZGNXResearch Report) and Walgreens Boots Alliance (WBAResearch Report).

Inovio Pharmaceuticals is up 18.24% in midday trading to $10.63. Shares opened today at $8.99. The company has a 52-week low of $2.19 and a 52-week high of $33.79. On the Street’s front, the average 12-month analyst price target for the stock is $13.57, marking a 50.95% potential upside from current levels. In a report released today, RBC analyst Gregory Renza maintained a Hold rating on INO, with a price target of $11.00, which implies an upside of 22% from current levels. Separately, yesterday, Maxim Group’s Jason McCarthy maintained a Buy rating on the stock and has a price target of $20.00.

Kandi Technologies is down -9.87% in midday trading to $6.03. Shares opened today at $6.69. The company has a 52-week low of $2.17 and a 52-week high of $17.40.

Novavax is down -9.52% in midday trading to $77.18. Shares opened today at $85.30. The company has a 52-week low of $3.54 and a 52-week high of $189.40. On the Street’s front, the average 12-month analyst price target for the stock is $199.75, marking a 134.17% potential upside from current levels. In a report released today, Ladenburg Thalmann analyst Michael Higgins reiterated a Sell rating on NVAX, with a price target of $75.00, which represents a potential downside of 12% from where the stock is currently trading. Separately, yesterday, B.Riley Financial’s Mayank Mamtani reiterated a Buy rating on the stock and has a price target of $223.00. Over the last 3 months, the insider sentiment on Novavax has been negative based on 26 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Zogenix is up 8.88% in midday trading to $22.53. Shares opened today at $20.69. The company has a 52-week low of $16.65 and a 52-week high of $57.22. On the Street’s front, the average 12-month analyst price target for the stock is $48.25, marking a 133.18% potential upside from current levels. In a report released today, Ladenburg Thalmann analyst Michael Higgins maintained a Hold rating on ZGNX, with a price target of $25.00, which implies an upside of 21% from current levels. Separately, on the same day, Northland Securities’ Carl Byrnes assigned a Buy rating to the stock and has a price target of $65.00.

Walgreens Boots Alliance is up 8.26% in midday trading to $43.09. Shares opened today at $39.80. The company has a 52-week low of $33.36 and a 52-week high of $63.24. On the Street’s front, the average 12-month analyst price target for the stock is $38.56, marking a -3.12% potential downside from current levels. In a report issued on October 16, Citigroup analyst Ralph Giacobbe maintained a Hold rating on WBA, with a price target of $40.00, which represents a slight upside potential from current levels. Separately, on October 7, Merrill Lynch’s Michael Cherny reiterated a Sell rating on the stock and has a price target of $37.00. In the last 30 days, insiders have sold $2.47M worth of WBA shares.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.